NGVT · Categories · Earnings
NGVT - Earnings announcements
Ingevity Corporation (NGVT) earnings announcements - real-time wire coverage filtered to Earnings only.
Recent Earnings for NGVT
- Ingevity reports first quarter 2026 financial resultsFirst Quarter 2026 Results & Recent Highlights: Net sales of $258.0 million increased 4% from prior year Net income from continuing operations of $23.4 million and $0.65 per diluted share compared to $29.1 million and $0.79 in the prior year Adjusted earnings from continuing operations of $41.4 million and $1.15 of diluted earnings per share compared to $37.0 million and $1.01 in the prior year Adjusted EBITDA from continuing operations of $91.5 million, flat to prior year; Adjusted EBITDA margin of 35.5% compared to 36.8% in the prior year Completed sale of North Charleston refinery assets and the majority of Performance Chemicals Industrial Specialties product line on Janua
- Ingevity announces dates for first quarter 2026 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its first quarter 2026 earnings after the stock market close on Wednesday, May 6, 2026. The company will host a live webcast on Thursday, May 7, at 10:00 a.m. (Eastern) to discuss first quarter 2026 fiscal results. Registration for the webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 616645588. Callers outside the U.S. can find international dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (
- Ingevity reports full year and fourth quarter 2025 financial resultsHighlights: Strong business performance in 2025 drove higher earnings and robust cash flow, enabling meaningful debt reduction and return of capital to shareholders Completed sale of North Charleston crude tall oil refinery assets and the majority of Performance Chemicals Industrial Specialties product line Concluded portfolio review and initiated the exploration of strategic alternatives for Advanced Polymer Technologies segment and the Performance Chemicals Road Markings product line Full Year: Total net sales of $1.3 billion, from continuing and discontinued operations, decreased 8% from prior year; net sales from continuing operations of $1.2 billion, down 3% versus prior
- Ingevity announces dates for fourth quarter and full year 2025 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its fourth quarter and full year 2025 earnings after the stock market close on Wednesday, February 25, 2026. The company will host a live webcast on Thursday, February 26, at 10:00 a.m. (Eastern) to discuss fourth quarter and full year 2025 fiscal results. The webcast can be accessed via the investors section of Ingevity's website. Participants may pre-register for the event here. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 102386. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recordin
- Ingevity announces results of portfolio review, including plans to explore strategic alternatives for Advanced Polymer Technologies segment and Road Markings businessPotential divestitures would further enhance portfolio to focus on core businesses which carry best-in-class margins and cash flow generation Ingevity Corporation (NYSE:NGVT) today announced it has completed the company's previously disclosed portfolio review process and is in the early stages of exploring strategic alternatives for its Advanced Polymer Technologies (APT) segment and Performance Chemicals Road Markings business, including a potential sale of one or both. "Ingevity's leadership team and Board remain focused on unlocking long-term value for shareholders," said Dave Li, president and CEO of Ingevity. "Having conducted a thorough review of the Ingevity portfolio, we have dete
- Ingevity announces dates for third quarter 2025 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its third quarter 2025 earnings after the stock market close on Wednesday, November 5, 2025. The company will host a live webcast on Thursday, November 6, at 10:00 a.m. (Eastern) to discuss third quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 871022. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on Novem
- Ingevity reports second quarter 2025 financial resultsHIGHLIGHTS: Net sales of $365.1 million, down 7% compared to prior year, primarily due to lower sales in Performance Chemicals Net loss of $146.5 million and diluted loss per share of $4.02 included an Advanced Polymer Technologies pre-tax non-cash goodwill impairment charge of $183.8 million Adjusted earnings of $51.1 million were up 39% and diluted adjusted earnings per share of $1.39 was up 38% Adjusted EBITDA of $110.0 million increased 9% and adjusted EBITDA margin improved to 30.1% primarily due to the successful execution of repositioning actions in Performance Chemicals Operating cash flow of $79.0 million with free cash flow of $66.8 million Ingevity raises the lo
- Ingevity announces dates for second-quarter 2025 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2025 earnings after the stock market close on Monday, August 4, 2025. The company will host a live webcast on Tuesday, August 5, at 10:00 a.m. (Eastern) to discuss second-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 590026. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on August 5, 2
- Ingevity reports first quarter 2025 financial resultsHIGHLIGHTS: Net sales of $284.0 million, down 17% compared to prior year, primarily due to repositioning actions in Performance Chemicals, which included the exit of certain lower-margin end markets Net income of $20.5 million and diluted earnings per share (EPS) of $0.56 reflects before-tax special charges of $20.2 million; adjusted earnings of $36.4 million and diluted adjusted EPS of $0.99 Adjusted EBITDA of $91.3 million increased 23% and adjusted EBITDA margin improved to 32.1% due primarily to the successful execution of repositioning actions in Performance Chemicals and continued strong profitability in Performance Materials Operating cash flow of $25.4 million with free cash
- Ingevity announces dates for first-quarter 2025 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its first-quarter 2025 earnings after the stock market close on Monday, May 5, 2025. The company will host a live webcast on Tuesday, May 6, at 9:00 a.m. (Eastern) to discuss first-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 815699. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 6, 2025, through M
- Ingevity reports fourth quarter and full year 2024 financial resultsFourth Quarter: Net sales of $298.8 million decreased 20% compared to prior year primarily due to repositioning actions in the Performance Chemicals segment that resulted in the exit of lower-margin end markets Net income of $16.6 million and diluted earnings per share (EPS) of $0.46, including pre-tax restructuring charges of $23.4 million; adjusted earnings of $34.7 million and diluted adjusted EPS of $0.95 Adjusted EBITDA of $80.6 million and adjusted EBITDA margin of 27.0% Operating cash flow of $64.5 million and free cash flow of $39.6 million, which included the second and final $50.0 million installment of a termination fee for a long-term crude tall oil (CTO) supply agreemen
- Ingevity announces plans to explore strategic alternatives for Performance Chemicals Industrial Specialties product line and North Charleston CTO refinery; releases preliminary 2024 financial resultsExiting of targeted product line expected to further strengthen the Performance Chemicals segment and improve Ingevity's overall earnings and cash flow profile Evaluating additional potential actions to maximize shareholder value Full year 2024 Net sales expected to be approximately $1.40 billion; Adjusted EBITDA of approximately $360 million Ingevity Corporation (NYSE:NGVT) today announced that it is exploring strategic alternatives for the company's Performance Chemicals Industrial Specialties product line, including a potential divestiture of portions of its North Charleston site. Ingevity noted that this process includes all Industrial Specialties pine chemical-based chemistri
- Ingevity announces dates for fourth-quarter and full year 2024 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its fourth-quarter and full year 2024 earnings after the stock market closes on Tuesday, February 18, 2025. The company will host a live webcast on Wednesday, February 19, at 10:00 a.m. (Eastern) to discuss Ingevity's fourth-quarter and full year 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 068901. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at
- Ingevity reports third quarter 2024 financial resultsHIGHLIGHTS: Net sales of $376.9 million, down 16% compared to prior year, primarily due to repositioning actions in Performance Chemicals Net loss of $107.2 million and diluted loss per share of $2.95 reflects before-tax restructuring charges of $86.9 million and contract termination fees of $100.0 million; adjusted earnings of $40.2 million and diluted adjusted earnings per share (EPS) of $1.10 Adjusted EBITDA of $106.4 million and adjusted EBITDA margin of 28.2% Operating cash flow of $46.5 million with free cash flow of $28.5 million Affirms full year guidance of sales between $1.40 billion and $1.50 billion and adjusted EBITDA between $350 million and $360 million The result
- Ingevity updates third-quarter 2024 earnings release and webcast datesIngevity Corporation (NYSE:NGVT) announced today that it will release its third-quarter 2024 earnings after the stock market close on Tuesday, October 29, 2024. The company will host a live webcast on Wednesday, October 30, at 10:00 a.m. (Eastern) to discuss third-quarter 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 381718. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on October 30, 2024,
- Ingevity announces additional steps to advance strategic repositioning and improve profitability of its Performance Chemicals segmentWill optimize existing manufacturing footprint by consolidating oleo-based chemical refining with existing crude tall oil refining at the company's North Charleston, South Carolina, facility, and closing its Crossett, Arkansas, facility in August Manufacturing consolidation will result in approximately $20 million to $25 million in annual savings beginning in 2025 Executes corporate and business-related cost reduction actions resulting in additional annual savings of approximately $10 million beginning in 2025 Expects charges associated with these actions of approximately $100 million, with approximately $65 million to be non-cash Continues to evaluate the Performance Chemicals
- Ingevity reports second quarter 2024 financial resultsHIGHLIGHTS: Net sales of $390.6 million, down 19% compared to prior year Net loss of $283.7 million and diluted loss per share of $7.81 primarily due to a Performance Chemicals non-cash goodwill impairment charge; adjusted earnings of $36.8 million and diluted adjusted earnings per share (EPS) of $1.01 Adjusted EBITDA of $101.3 million and adjusted EBITDA margin of 25.9% Operating cash flow of $29.7 million with free cash flow of $11.6 million In July, the company took further actions to reposition its Performance Chemicals segment, including the termination of a long-term crude tall oil supply contract, the announced closure of its Crossett, Arkansas, facility, to consolidat
- Ingevity announces dates for second-quarter 2024 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2024 earnings after the stock market close on Wednesday, July 31, 2024. The company will host a live webcast on Thursday, August 1, at 11:00 a.m. (Eastern) to discuss second-quarter 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 153840. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on August 1, 2024, t
- Ingevity reports first quarter 2024 financial resultsHIGHLIGHTS: (comparisons versus prior year period) Net sales of $340.1 million, down 13% primarily as a result of the repositioning of Performance Chemicals Net loss of $56.0 million and diluted loss per share (EPS) of $1.54; adjusted earnings of $19.1 million and diluted adjusted EPS of $0.52 Adjusted EBITDA of $76.9 million and adjusted EBITDA margin of 22.6% Operating cash flow of negative $12.1 million with free cash flow of negative $28.7 million reflecting normal seasonal inventory build and cash losses on crude tall oil (CTO) resales of $19.8 million Realized approximately $20 million of cost savings in Q1; on track for $65 million to $75 million of cost savings in 202
- Ingevity announces dates for first-quarter 2024 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its first-quarter 2024 earnings after the stock market close on Wednesday, May 1, 2024. The company will host a live webcast on Thursday, May 2, at 10:00 a.m. (Eastern) to discuss first-quarter 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 707574. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 2, 2024, through May
- Ingevity reports fourth quarter and full year 2023 financial resultsFourth Quarter (comparisons versus prior year period): Net sales of $371.7 million decreased 3.1% Net loss of $116.8 million and diluted loss per share of $3.23, including restructuring charges of $107.5 million; adjusted earnings of $7.8 million and diluted adjusted earnings per share (EPS) of $0.21 Adjusted EBITDA of $61.8 million and adjusted EBITDA margin of 16.6% Accelerated the repositioning of the Performance Chemicals segment including the shutdown of the DeRidder, Louisiana, crude tall oil (CTO) refinery completed in early February of 2024 with the remaining assets to be shut down during the first half of the year Implemented significant cost savings actions Full
- Ingevity announces dates for fourth-quarter and full year 2023 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its fourth-quarter and full year 2023 earnings after the stock market close on Wednesday, February 21, 2024. The company will host a live webcast on Thursday, February 22, at 9:00 a.m. (Eastern) to discuss fourth-quarter and full year 2023 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 690825. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p
- Ingevity reports third quarter 2023 financial resultsHIGHLIGHTS: (comparisons versus prior year period) Net sales of $446.0 million, down 7%, compared to a record prior year Net income of $25.2 million and diluted earnings per share (EPS) of $0.69; adjusted earnings of $44.2 million and diluted adjusted EPS of $1.21 Adjusted EBITDA of $110.4 million and adjusted EBITDA margin of 24.8% Operating cash flow of $106.9 million with free cash flow of $73.4 million Updated 2023 full-year guidance for adjusted EBITDA between $375 million to $390 million The company also announced today actions to accelerate the repositioning of its Performance Chemicals segment, including the closure of its DeRidder, Louisiana, facility and company-
- Ingevity announces further repositioning of its Performance Chemicals business, including the closure of its DeRidder, Louisiana, facility and additional company-wide cost reduction actionsCompany taking next steps in executing strategy that focuses on higher margin and higher growth specialty products, diversifies feedstocks and optimizes manufacturing network Exiting certain commodity-oriented markets that are primarily rosin-based Reducing exposure to structurally more expensive crude tall oil (CTO) raw material that is being dramatically impacted by the biofuels market; company plans to sell excess CTO Closing DeRidder facility by the end of the first half of 2024 Company will operate a dual CTO and Alternative Fatty Acid (AFA) refinery network to maximize profitability and reduce raw material cost volatility Total estimated business and corporate savings
- Ingevity announces dates for third-quarter 2023 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its third-quarter 2023 earnings after the stock market close on Wednesday, November 1, 2023. The company will host a live webcast on Thursday, November 2, at 10:00 a.m. (Eastern) to discuss third-quarter 2023 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) or 929 526 1599 (outside the U.S.) and entering access code 140564. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on November 2, 2023, through November 1, 2024
- Ingevity reports second quarter 2023 financial resultsHIGHLIGHTS: (comparisons versus prior year period) Net sales of $481.8 million, up 15% Net income of $35.5 million and diluted earnings per share (EPS) of $0.97; adjusted earnings of $51.6 million and diluted adjusted EPS of $1.41 Adjusted EBITDA of $120.7 million and adjusted EBITDA margin of 25.1% Operating cash flow of $48.4 million with free cash flow of $26.7 million Initiated cost reduction actions with anticipated annualized savings of approximately $35 million with $20 million expected to be realized in 2023 Adjusted 2023 guidance for sales between $1.6 billion to $1.7 billion and adjusted EBITDA between $390 million to $420 million The results and guidance in t
- Ingevity announces dates for second-quarter 2023 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2023 earnings after the stock market close on Wednesday, August 2, 2023. The company will host a live webcast on Thursday, August 3, at 10:00 a.m. (Eastern) to discuss second-quarter 2023 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) or 929 526 1599 (outside the U.S.) and entering access code 566352. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on August 3, 2023, through August 2, 2024, at t
- Ingevity reports first quarter 2023 financial resultsHIGHLIGHTS: (comparisons versus prior year period) Net sales of $392.6 million, up 2.6% Net income of $50.7 million and diluted earnings per share (EPS) of $1.35; adjusted earnings of $41.1 million and diluted adjusted EPS of $1.09 Adjusted EBITDA of $103.9 million and adjusted EBITDA margin of 26.5% Operating cash flow of $5.2 million with free cash flow of negative $20.2 million, reflecting seasonal inventory build Share repurchases of $33.4 million Converting Crossett, AR plant to run 100% on non-CTO feedstocks to produce oleo-based alternate fatty acids (AFA) Adjusted 2023 guidance for sales between $1.75 billion to $1.95 billion and adjusted EBITDA between $450 mil
- Ingevity announces dates for first-quarter 2023 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its first-quarter 2023 earnings after the stock market close on Wednesday, May 3, 2023. The company will host a live webcast on Thursday, May 4, at 10:00 a.m. (Eastern) to discuss first-quarter 2023 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) or 929 526 1599 (outside the U.S.) and entering access code 122397. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 4, 2023, through May 3, 2024, at this replay lin
- Ingevity reports fourth quarter and full year 2022 financial resultsHighlights: Full year 2022 was a record year for both net sales and EBITDA, driven by growth across all business segments; fourth quarter results were negatively impacted primarily by significant customer destocking in the second half of the quarter. Fourth Quarter (comparisons versus prior year period): Net sales of $383.6 million increased 14.2%; Net income of $15.6 million and diluted earnings per share (EPS) of $0.41; adjusted earnings of $21.5 million and diluted adjusted EPS of $0.57 Adjusted EBITDA of $74.3 million and adjusted EBITDA margin of 19.4% Share repurchases of $6.0 million Full Year (comparisons versus prior year period): Net sales of $1.67 billion increased
- Ingevity announces dates for fourth-quarter and full-year 2022 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its fourth-quarter and full-year 2022 earnings after the stock market close on Monday, February 27, 2023. The company will host a live webcast on Tuesday, February 28, at 10:00 a.m. (Eastern) to discuss fourth-quarter and full-year 2022 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 844 200 6205 (inside the U.S.) or 929 526 1599 (outside the U.S.) and entering access code 696144. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on February 28, 202
- Ingevity reports third quarter 2022 financial resultsHIGHLIGHTS: (comparisons versus prior year period) Company delivered record sales of $482.0 million, up 27.9% Net income of $75.4 million and diluted earnings per share (EPS) of $1.98; adjusted earnings of $79.4 million and record diluted adjusted EPS of $2.09 Record adjusted EBITDA of $138.2 million, up 15.6% and adjusted EBITDA margin of 28.7% Operating cash flow of $100.1 million and free cash flow of $64.0 million Share repurchases were $49.3 million for the quarter and $139.2 million year to date Completed the acquisition of Ozark Materials on October 3rd Company raises full year 2022 sales guidance to between $1.65 billion and $1.70 billion and adjusted EBITDA to between
- Ingevity announces dates for third quarter 2022 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its third quarter 2022 earnings after the stock market close on Wednesday, November 2, 2022. The company will host a live webcast on Thursday, November 3, 2022, at 10:00 a.m. (Eastern) to discuss third quarter 2022 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 844 200 6205 (inside the U.S.) or 929 526 1599 (outside the U.S.) and entering access code 110669. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on November 3, 2022, through November 3,
- Ingevity reports second quarter 2022 financial resultsHIGHLIGHTS: (comparisons versus prior year period) Company delivered record sales of $419.9 million, up 17.2% Net income of $59.8 million and diluted earnings per share (EPS) of $1.54; adjusted earnings of $67.0 million and diluted adjusted EPS of $1.73 Second highest quarterly EBITDA of $121.1 million, up 2.9% and adjusted EBITDA margin of 28.8% Operating cash flow of $90.5 million and free cash flow of $60.9 million The Company also announced two strategic growth investments: An agreement to acquire Ozark Materials, a leading producer of pavement marking materials, for $325.0 million which strengthens the Company's position in this growing market and complements our existing i
- Ingevity announces dates for second quarter 2022 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its second quarter 2022 earnings after the stock market close on Tuesday, August 2, 2022. The company will host a live webcast on Wednesday, August 3, 2022, at 10:00 a.m. (Eastern) to discuss second quarter 2022 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 927 1758 (inside the U.S.) or 929 526 1599 (outside the U.S.) and entering access code 067253. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on August 3, 2022, through August 2, 2023, a
- Ingevity reports first quarter 2022 financial resultsHIGHLIGHTS: (comparisons versus prior year period) Company delivered strong results driven by record sales of $382.8 million, up 19.5% Net income of $60.8 million and diluted earnings per share (EPS) of $1.55; adjusted earnings of $63.5 million and diluted adjusted EPS of $1.62 Record first quarter adjusted EBITDA of $119.0 million, up 12.9% and adjusted EBITDA margin of 31.1% Operating cash flow of $24.3 million and free cash flow of negative $3.3 million, reflecting working capital increases driven by the strong sales Company adjusts full year 2022 guidance increasing the top ends of the ranges to sales between $1.525 billion and $1.65 billion and adjusted EBITDA between $430 mi
- Ingevity announces dates for first quarter 2022 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its first quarter 2022 earnings after the stock market close on Wednesday, May 4, 2022. The company will host a live webcast on Thursday, May 5, 2022, at 10:00 a.m. (Eastern) to discuss first quarter 2022 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 844 200 6205 (inside the U.S.) or 929 526 1599 (outside the U.S.) and entering access code 080961. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 5, 2022 through May 4, 2023 at this replay l
- Ingevity reports fourth-quarter and full-year 2021 financial resultsHIGHLIGHTS: (comparisons versus prior year period) Company delivered solid results despite supply chain challenges and inflationary cost pressures, and the continuing microchip shortage that negatively impacted fourth-quarter (Q4) and full-year (FY) performance Net sales in Q4 of $336.0 million increased 3.2%, with FY net sales of $1.4 billion up 14.4% Q4 net income of $29.3 million and diluted earnings per share (EPS) of $0.74; Q4 adjusted earnings of $30.9 million and diluted adjusted EPS of $0.78 FY net income of $118.1 million and diluted EPS of $2.95, reflecting an $85 million litigation verdict charge that had a $1.63 impact, net of tax, to diluted EPS; FY adjusted earnings of
- Ingevity announces dates for fourth-quarter and full-year 2021 earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its fourth-quarter and full-year 2021 earnings after the stock market close on Wednesday, February 23, 2022. The company will host a live webcast on Thursday, February 24, 2022, at 10:00 a.m. (Eastern) to discuss fourth-quarter and full-year 2021 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 844 200 6205 (inside the U.S.) or 929 526 1599 (outside the U.S.) and entering access code 751599. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on Februa
- Ingevity reports third quarter 2021 financial resultsHIGHLIGHTS: (comparisons versus prior year period) Third quarter net sales of $376.8 million, up 13.6% Net loss of $4.2 million reflects an $85 million pre-tax expense for a litigation verdict, which had an after-tax impact on earnings of $1.64 per share Adjusted earnings of $64.4 million and adjusted earnings per share of $1.62 Adjusted EBITDA of $119.5 million and adjusted EBITDA margin of 31.7% Operating cash flow of $100.1 million drove free cash flow of $74.6 million Company updates full year 2021 guidance to sales between $1.320 billion and $1.360 billion and adjusted EBITDA between $405 million and $420 million The results and guidance in this release include non-GAAP f
- Ingevity announces dates for third quarter earnings release and webcastIngevity Corporation (NYSE:NGVT) announced today that it will release its third quarter earnings after the stock market close on Wednesday, October 27, 2021. The company will host a live webcast on Thursday, October 28, 2021, at 10:00 a.m. (Eastern) to discuss third quarter 2021 fiscal results. The webcast can be accessed through the investors section of Ingevity's website or via this link: Ingevity Q3 2021 earnings webcast. You may also listen to the conference call by dialing 877-407-2991 (inside the U.S.) or 201-389-0925 (outside the U.S.), at least 10 minutes prior to the start of the event. For those unable to join the live event, a replay of the webcast will be available beginning a
- Ingevity reports second quarter 2021 financial results and increases full year 2021 guidanceHIGHLIGHTS: (comparisons versus prior year period) Ingevity delivers strong second quarter results driven by higher volumes and supported by price increases across both segments Net sales of $358.4 million up 32.4% Net income of $44.3 million rose 119.3%; net income margin of 12.4%, up 490 basis points Adjusted EBITDA of $117.7 million rose 75.1%; adjusted EBITDA margin of 32.8%, up 800 basis points Operating cash flow of $65.8 million drove free cash flow up 23.6% to $41.9 million Company increases full year 2021 guidance to sales between $1.320 billion and $1.360 billion and adjusted EBITDA between $425 million and $440 million The results and guidance in this release includ